Zhong Yuan Bio-Technology Holdings Limited
ZHYBF
Rank in Stocks
#24136
Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived... Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived nervonic acid dietary supplements in China. It operates through four segments: Sales of Dietary Supplements; Research and Development Services; Royalties; and Event Organization. It also develops early detection kits for brain diseases and new drugs for neurological diseases; and technical supporting services. It sells its products under the Muzhiyuan-Neuro Enhancer brand. Zhong Yuan Bio-Technology Holdings Limited Limited is based in Wanchai, Hong Kong.
Share Price
$2.02
Last synced: 2026-11-06
Market Cap
$35.75M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Zhong Yuan Bio-Technology Holdings Limited (ZHYBF)
Category
Healthcare
Operating Margin for Zhong Yuan Bio-Technology Holdings Limited (ZHYBF)
Operating Margin as of November 2026 TTM: 11.70%
According to Zhong Yuan Bio-Technology Holdings Limited's latest financial reports, its current operating margin (TTM) is 11.70%. At the end of 2024 the company had an operating margin of 11.70%.
Operating Margin history for Zhong Yuan Bio-Technology Holdings Limited from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 11.70% | 0.00% |
| 2024 | 11.70% | -115.52% |
| 2023 | -75.39% | 155.99% |
| 2022 | -29.45% | 3,208.99% |
| 2021 | -0.89% | -87.30% |
| 2020 | -7.01% | -127.34% |
| 2019 | 25.64% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 1.62% | -99.86% |
US
|
|
| 1.30% | -99.89% |
US
|
|
| 1.03% | -99.91% |
US
|
|
| 0.91% | -99.92% |
US
|
|
| 9.21% | -99.21% |
AU
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Zhong Yuan Bio-Technology Holdings Limited's operating margin
What is Zhong Yuan Bio-Technology Holdings Limited's operating margin?
Zhong Yuan Bio-Technology Holdings Limited's operating margin is 11.70%, as of Nov 2026.
What was Zhong Yuan Bio-Technology Holdings Limited's operating margin in 2024?
In 2024, Zhong Yuan Bio-Technology Holdings Limited's operating margin was 11.70%, compared with -75.39% in 2023.
How has Zhong Yuan Bio-Technology Holdings Limited's operating margin changed since 2019?
From 2019 to 2024, Zhong Yuan Bio-Technology Holdings Limited's operating margin was highest in 2019 (25.64%) and lowest in 2023 (-75.39%).
How does Zhong Yuan Bio-Technology Holdings Limited's operating margin compare with similar companies?
Zhong Yuan Bio-Technology Holdings Limited's operating margin (11.70%) is higher than that of all 5 similar companies listed above. The highest among them is Sigma Healthcare Limited, with 9.21%.